State-Backed Guarantees for Essential Therapies Supply

Introduction

State-Backed Guarantees for Essential Therapies Supply refer to the legal, constitutional, and administrative measures through which governments ensure the continuous availability, affordability, accessibility, and distribution of essential medicines, vaccines, biological products, and life-saving treatments.

Essential therapies include medicines for cancer, HIV/AIDS, tuberculosis, diabetes, rare genetic disorders, infectious diseases, and other serious medical conditions.

The government has an important responsibility to prevent shortages, excessive pricing, artificial scarcity, and discriminatory distribution of essential treatments. These guarantees are particularly important during pandemics, public health emergencies, and medical supply-chain disruptions.

In India, this subject is closely connected with Article 21 of the Constitution, public health legislation, pharmaceutical price regulation, and the government's responsibility to protect human life.

1. Meaning and Objectives

State-backed guarantees involve government policies and legal mechanisms designed to ensure that essential therapies remain available to the population.

Their principal objectives include:

Ensuring uninterrupted supplies of life-saving medicines.

Making essential therapies affordable for economically weaker sections.

Preventing artificial shortages and pharmaceutical hoarding.

Regulating prices of essential medicines.

Ensuring equitable distribution during public health emergencies.

Supporting domestic pharmaceutical manufacturing and public procurement.

Protecting patients against discriminatory access to treatment.

2. Constitutional Framework in India

Several constitutional provisions support government responsibility for essential therapies.

Article 21: Protects the right to life, which includes important aspects of access to healthcare and medical treatment.

Article 14: Guarantees equality and prevents arbitrary discrimination in the distribution of essential medicines.

Article 19(1)(g): Protects pharmaceutical business activities, subject to reasonable restrictions under Article 19(6).

Article 38: Directs the State to promote social welfare and reduce inequalities.

Article 39(e): Requires protection of workers' health and strength.

Article 47: Makes improvement of public health one of the primary duties of the State.

These provisions collectively support the development of an accessible and affordable healthcare system.

3. Legislative and Regulatory Framework

A. Essential Commodities Act, 1955

Section 3 empowers the Central Government to regulate the production, supply, distribution, and trade of essential commodities in the public interest. Medicines can be regulated under this framework to prevent shortages and ensure availability.

B. Drugs (Prices Control) Order, 2013

The DPCO, 2013 regulates prices of scheduled medicines through ceiling prices fixed by the National Pharmaceutical Pricing Authority (NPPA). Paragraph 21 also provides a mechanism for controlling discontinuation of scheduled formulations, including requiring continued production or import in specified circumstances.

Digital Sansad+1

C. Drugs and Cosmetics Act, 1940

This legislation regulates the import, manufacture, distribution, and sale of drugs in India. It establishes quality and licensing requirements to protect patients against unsafe or substandard medicines.

D. National Health Mission

The National Health Mission supports public healthcare infrastructure, essential medicine availability, and healthcare delivery through Central and State Government programmes.

E. Pradhan Mantri Bhartiya Janaushadhi Pariyojana

This government initiative promotes access to quality generic medicines at affordable prices through dedicated Jan Aushadhi Kendras.

4. Important Case Laws

1. Paschim Banga Khet Mazdoor Samity v. State of West Bengal (1996), 4 SCC 37

The Supreme Court held that failure of government hospitals to provide timely medical treatment can violate Article 21. It recognised the State's responsibility to develop an effective healthcare system and provide necessary medical facilities.

This judgment establishes an important constitutional foundation for ensuring access to essential therapies.

2. Mohd. Ahmed (Minor) v. Union of India (2014), Delhi High Court, W.P.(C) 7279/2013

The case concerned a child suffering from Gaucher disease who required expensive, lifelong enzyme replacement therapy.

The Delhi High Court examined the State's obligation to provide access to life-saving medicines under Article 21. It emphasised that the government must consider the needs of vulnerable patients, including those suffering from rare diseases, while framing healthcare policies.

The judgment is particularly relevant to government-backed guarantees for expensive essential therapies.

Indian Kanoon+1

3. State of Punjab v. Ram Lubhaya Bagga (1998), 4 SCC 117

The Supreme Court examined the government's authority to modify its medical reimbursement policy in view of financial limitations. It recognised that healthcare policy must consider available resources, but government decisions remain subject to constitutional and legal review.

This case demonstrates the balance between the State's healthcare obligations and financial capacity.

4. In Re: Distribution of Essential Supplies and Services During Pandemic (2021), 2021 INSC 280

The Supreme Court addressed the distribution of oxygen, essential medicines, vaccines, and healthcare services during COVID-19.

It examined supply shortages, equitable allocation, price regulation, and coordination between Central and State Governments. The Court emphasised that government policies must comply with Articles 14 and 21.

This judgment is particularly important for ensuring continuity of essential medical supplies during national emergencies.

VoxJuris

5. Union of India v. K.S. Gopinath (2003), Supreme Court

The Supreme Court emphasised the importance of ensuring that essential and life-saving medicines remain under appropriate price-control measures. This principle influenced the development of policies concerning the affordability of essential medicines.

VoxJuris+1

5. Major Legal and Ethical Challenges

Medicine shortages: Government agencies must develop effective procurement and distribution systems.

High treatment costs: Expensive medicines may remain inaccessible to economically weaker patients.

Pharmaceutical monopolies: Limited competition can affect availability and affordability.

Unequal distribution: Rural and economically disadvantaged communities may experience difficulties accessing therapies.

Intellectual property rights: Patent protection must be balanced with public health requirements and lawful compulsory licensing.

Quality control: Affordable medicines must also satisfy applicable safety and quality standards.

6. Role and Responsibility of the State

The government should establish reliable procurement systems, maintain emergency medicine reserves, regulate essential drug prices, support domestic pharmaceutical manufacturing, and monitor medicine shortages.

It should also develop transparent allocation policies, strengthen public hospitals, encourage generic medicines, and use compulsory licensing where statutory conditions are satisfied.

Conclusion

State-Backed Guarantees for Essential Therapies Supply represent an important intersection of constitutional law, pharmaceutical regulation, public health, and social justice. Articles 14 and 21 provide constitutional foundations for equitable healthcare access, while the Essential Commodities Act, 1955, DPCO, 2013, and Drugs and Cosmetics Act, 1940, provide regulatory mechanisms.

The Indian judiciary has recognised that access to necessary medical treatment is an important component of the right to life. Ultimately, the State must work towards ensuring that essential therapies are available, affordable, safe, and accessible without discrimination.

Legal clarification: Article 21 does not establish an unconditional guarantee that every medicine or treatment must be provided free of cost in every circumstance. The scope of the State's obligation depends on constitutional principles, applicable legislation, healthcare policies, and available resources.